Cargando…

Comparative evaluation of staging algorithms proven N2 non-small cell lung cancer treated by lung resection after neoadjuvant therapy

BACKGROUND: In this study, we aimed to compare the performances of clinical methods, minimally invasive methods, mediastinoscopy, and re-mediastinoscopy used in the restaging of patients receiving neoadjuvant therapy for pathologically proven N2. Our secondary objective was to determine the most opt...

Descripción completa

Detalles Bibliográficos
Autores principales:	İşgörücü, Özgür, Çıtak, Necati, Açıkmeşe, Barış, Akalın Fener, Neslihan, Büyükkale, Songül, Sayar, Adnan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bayçınar Medical Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580280/ https://www.ncbi.nlm.nih.gov/pubmed/36303707 http://dx.doi.org/10.5606/tgkdc.dergisi.2022.21347

Ejemplares similares

The first long-term survival results of lung transplantation in Turkey
por: Çıtak, Necati, et al.
Publicado: (2021)

Impact of preoperative comorbidities on postoperative complication rate and outcome in surgically resected non-small cell lung cancer patients
por: Benker, Martina, et al.
Publicado: (2021)

Endotracheal ectopic parathyroid adenoma mimicking asthma
por: Özgül, M. Akif, et al.
Publicado: (2014)

Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023)

Subnormothermic Ex Vivo Lung Perfusion Temperature Improves Graft Preservation in Lung Transplantation
por: Arni, Stephan, et al.
Publicado: (2021)

Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer
por: Tfayli, Arafat, et al.
Publicado: (2020)

Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer
por: Chen, Yulong, et al.
Publicado: (2021)

Perfluorocarbon-Based Oxygen Carriers and Subnormothermic Lung Machine Perfusion Decrease Production of Pro-Inflammatory Mediators
por: Arni, Stephan, et al.
Publicado: (2021)

Neoadjuvant pembrolizumab with chemotherapy for the treatment of stage IIB–IIIB resectable lung squamous cell carcinoma
por: Shen, Dijian, et al.
Publicado: (2021)

Role of surgery in high-grade neuroendocrine tumors of the lung
por: Bedirhan, Mehmet Ali, et al.
Publicado: (2022)

Major pulmonary resection after neoadjuvant chemotherapy or chemoradiation in potentially resectable stage III non-small cell lung carcinoma
por: Peer, Michael, et al.
Publicado: (2021)

Safety and effectiveness of localized lung resection combined with neoadjuvant chemotherapy in the treatment of stage I–II non-small cell lung cancer
por: Zhu, Bing, et al.
Publicado: (2017)

Neoadjuvant immunotherapy in resectable non-small-cell lung cancer
por: Chen, Lanyi Nora, et al.
Publicado: (2023)

Confocal Microscopy in Biopsy Proven Argyrosis
por: Palamar, Melis, et al.
Publicado: (2013)

Prognostic value of epidermal growth factor receptor expression in operable non-small cell lung carcinoma
por: Seyhan, Ekrem Cengiz, et al.
Publicado: (2010)

Comparison of 6th, 7th, and 8th editions of the TNM staging in non-small cell lung cancer patients: Validation of the 8th edition of TNM staging
por: Erdoğu, Volkan, et al.
Publicado: (2022)

Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer
por: Zhao, Ze-Rui, et al.
Publicado: (2021)

An open, observational clinical study of neoadjuvant therapy in resectable stage III non-small cell lung cancer
por: Qi, Yuwen, et al.
Publicado: (2023)

SBRT for early stage lung cancer: outcomes from biopsy-proven and empirically treated lesions
por: Wegner, Rodney E, et al.
Publicado: (2018)

Is There Any Relationship Between the Number of COVID-19 Tests by Country with the Income Inequality of Countries? A Comparison with Income Inequality Metrics
por: Çıtak, Necati, et al.
Publicado: (2022)

Neoadjuvant PD‐1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung
por: Feng, Yuan, et al.
Publicado: (2021)

Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
por: Reuss, Joshua E, et al.
Publicado: (2020)

The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer
por: Jiang, Long, et al.
Publicado: (2021)

Neoadjuvant immunotherapy in resectable non-small cell lung cancer at a checkpoint
por: Faltermeier, Claire M., et al.
Publicado: (2021)

Neoadjuvant immunotherapy facilitates resection of surgically-challenging lung squamous cell cancer
por: Xu, Ke, et al.
Publicado: (2021)

Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer
por: Parekh, Jay, et al.
Publicado: (2023)

Pathologic Stage of Nonsmall Cell Lung Cancer Patients Presenting as Resectable Cases After Neoadjuvant Therapy Did Not Predict the Prognosis
por: Wu, Ching-Yang, et al.
Publicado: (2015)

Feasibility and surgical outcomes of video‐assisted thoracoscopic pulmonary resection in patients with advanced‐stage lung cancer after neoadjuvant chemoradiotherapy
por: Suh, Jee Won, et al.
Publicado: (2019)

Neoadjuvant pembrolizumab and chemotherapy in resectable clinical stage III non-small-cell lung cancer: a retrospective cohort study
por: Zhao, Guangyin, et al.
Publicado: (2023)

The impact of health literacy on COVID-19 immunization
por: Sayar, Merve Sefa, et al.
Publicado: (2023)

Biopsy-proven IgG4-related lung disease
por: Sun, Xuefeng, et al.
Publicado: (2016)

Early outcomes of lung resections in non-small cell lung cancer after COVID-19 pneumonia
por: Hekimoglu, Baris, et al.
Publicado: (2022)

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer
por: Sher, David J.
Publicado: (2017)

SARS-CoV-2 Infection-Induced Necrotising Sarcoid Granulomatosis
por: Koc, Aysu Sinem, et al.
Publicado: (2023)

Pathologic Stage of Nonsmall Cell Lung Cancer Patients Presenting as Resectable Cases After Neoadjuvant Therapy Did Not Predict the Prognosis: Erratum
Publicado: (2015)

The safety and efficacy of neoadjuvant programmed death 1 inhibitor therapy with surgical resection in stage IIIA non-small cell lung cancer
por: Wang, Jiangfeng, et al.
Publicado: (2021)

Prognostic factors in potentially resectable stage III non-small cell lung cancer receiving neoadjuvant treatment—a narrative review
por: Calvo, Virginia, et al.
Publicado: (2021)

Neoadjuvant camrelizumab and chemotherapy in patients with resectable stage IIIA squamous non-small-cell lung cancer: Clinical experience of three cases
por: Li, Xin, et al.
Publicado: (2022)

Comprehensive study of neoadjuvant targeted therapy for resectable non-small cell lung cancer
por: Bao, Yi, et al.
Publicado: (2021)

Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer. A Narrative Review
por: Gatteschi, Lavinia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_su842ncubjr1pfmfbcsv58g362